These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7591769)

  • 21. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
    Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
    Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan, with special reference to mustard gas exposure.
    Inada S; Hiragun K; Seo K; Yamura T
    J Dermatol; 1978 Apr; 5(2):49-60. PubMed ID: 353106
    [No Abstract]   [Full Text] [Related]  

  • 23. Bowenoid change in association with graft-versus-host disease: a cyclosporine toxicity?
    Bulengo-Ransby SM; Sahn EE; Metcalf JS; Maize JC
    J Am Acad Dermatol; 1994 Dec; 31(6):1052-4. PubMed ID: 7962756
    [No Abstract]   [Full Text] [Related]  

  • 24. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
    Keller B; Braathen LR; Marti HP; Hunger RE
    Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoembryonic antigen in skin and related tumours as determined by immunohistological techniques.
    Scurry J; de Boer WG
    Pathology; 1983 Oct; 15(4):379-84. PubMed ID: 6371679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
    Koh E; Kondoh N; Kaihara H; Fujioka H; Kitamura K
    Eur Urol; 1989; 16(5):398-400. PubMed ID: 2776813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sebaceous hyperplasia and basal cell carcinoma in a renal transplant patient receiving cyclosporine.
    Pakula A; Garden J
    J Am Acad Dermatol; 1992 Jan; 26(1):139-40. PubMed ID: 1732329
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
    Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
    Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic study of arsenic-induced skin lesions: no definite association with human papillomavirus.
    Ratnam KV; Espy MJ; Muller SA; Smith TF; Su WP
    J Am Acad Dermatol; 1992 Jul; 27(1):120-2. PubMed ID: 1320060
    [No Abstract]   [Full Text] [Related]  

  • 30. Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion.
    Heddle R; Bryant GD
    Chest; 1983 Dec; 84(6):776-7. PubMed ID: 6315314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of arsenical keratosis and Bowen's disease with acitretin.
    Yerebakan O; Ermis O; Yilmaz E; Basaran E
    Int J Dermatol; 2002 Feb; 41(2):84-7. PubMed ID: 11982642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Skin symptoms in chronic occupational arsenic poisoning].
    Hamada T; Horiguchi S
    Nihon Rinsho; 1977 Feb; 35(2):430-3. PubMed ID: 140255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chronic arsenic poisoning from the viewpoint of the dermatologist].
    Hums R
    Dermatol Monatsschr; 1983; 169(12):765-75. PubMed ID: 6667759
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutaneous malignancy related to cyclosporin A therapy.
    Green C; Hawk JL
    Clin Exp Dermatol; 1993 Jan; 18(1):30-1. PubMed ID: 8440049
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of Bowen's disease, Bowen's carcinoma and Gueyrat's erythroplasia with special reference to low-voltage radiotherapy].
    Schoefinius HH; Lukacs S; Braun-Falco O
    Hautarzt; 1974 Oct; 25(10):489-93. PubMed ID: 4448634
    [No Abstract]   [Full Text] [Related]  

  • 36. Arsenic-induced keratoses and Bowen's disease.
    Watson K; Creamer D
    Clin Exp Dermatol; 2004 Jan; 29(1):46-8. PubMed ID: 14723721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical study of the distribution of blood group antigens A, B and H in tumors of the epidermis].
    Seki Y; Nashiro K; Oohara K; Tamaki K; Ishibasi Y
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):717-21. PubMed ID: 3306054
    [No Abstract]   [Full Text] [Related]  

  • 38. [An immunohistochemical study of a papillomavirus antigen in bowenoid papulosis and Bowen's disease].
    Suzuki H; Morishima T
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1193-200. PubMed ID: 2832645
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous manifestations of chronic arsenicism: review of seventeen cases.
    Wong SS; Tan KC; Goh CL
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):179-85. PubMed ID: 9486671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of skin-associated lymphoid tissue in the carcinogenesis of arsenical skin cancer.
    Yu HS; Chen GS; Sheu HM; Kao JS; Chang KL; Yu CL
    Proc Natl Sci Counc Repub China B; 1992 Jan; 16(1):17-22. PubMed ID: 1385879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.